Bill > HB1753

This bill, titled the "MS Medical Cannabis Act; bring forward provisions relating to," aims to reintroduce and potentially amend various sections of Mississippi's existing medical cannabis law. It defines key terms such as "artificially derived cannabinoid," "bona fide practitioner-patient relationship," and "debilitating medical condition," which is a serious illness or condition that qualifies a patient for medical cannabis. The bill outlines the roles and responsibilities of state agencies like the Mississippi Department of Health (MDOH) and the Mississippi Department of Revenue (MDOR) in licensing, regulating, and overseeing medical cannabis establishments, which include cultivation facilities, dispensaries, and processing facilities. It details the process for patients to obtain registry identification cards, including requirements for practitioner certifications and background checks for designated caregivers. The bill also addresses operational aspects such as tracking cannabis from "seed-to-sale" using a statewide system, setting limits on allowable amounts of medical cannabis, and establishing rules for dispensaries, cultivation, and processing facilities, including licensing fees and operational restrictions. Furthermore, it clarifies that certain entities, like employers and insurance providers, are not required to cover or accommodate medical cannabis use, and it outlines penalties for violations of the act, while also providing for judicial review of agency decisions and establishing a Medical Cannabis Advisory Committee to provide recommendations on the program.

Health and Social Services

https://billstatus.ls.state.ms.us/2026/pdf/history/HB/HB1753.xml